Clinical Neuroendocrinology: An Introduction, second edition, is thoroughly updated and continues to fulfil the continued need for a concise, introductory description of the human neuroendocrine system in health and disease. The clinical implications of basic human neuroendocrinology are described and presented along with real clinical case studies and a selection of review questions in each chapter to help cement readers' knowledge. Recent important advances are revealed in new figures and up-to-date references from the clinical literature, such as the discovery of kisspeptin, its use in the treatment of amenorrhea and its application in IVF. The authors also describe the development of GLP-1 agonists, which are now available for the treatment of obesity. This is a key text for senior medical students deciding on a specialty, as well as residents and clinical fellows who are embarking on their chosen fields. The book also provides crucial clinical context for biomedical science graduate students and clinicians.
Loading metrics...
* Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.
Usage data cannot currently be displayed.
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.
The PDF of this book complies with version 2.1 of the Web Content Accessibility Guidelines (WCAG), covering newer accessibility requirements and improved user experiences and achieves the intermediate (AA) level of WCAG compliance, covering a wider range of accessibility requirements.
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
You get more than just short alt text: you have comprehensive text equivalents, transcripts, captions, or audio descriptions for substantial non‐text content, which is especially helpful for complex visuals or multimedia.
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.